The latest closing stock price for SAB Biotherapeutics as of April 08, 2025 is 1.15.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-989 today, roughly -1 times their original investment - a -67.37% compound annual growth rate over 4 years.
The all-time high SAB Biotherapeutics stock closing price was 112.40 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 5.01, which is 335.7% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 1.00, which is 13% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 2.92.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-989 today, roughly -1 times their original investment - a -67.37% compound annual growth rate over 4 years.
The all-time high SAB Biotherapeutics stock closing price was 112.40 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 5.01, which is 335.7% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 1.00, which is 13% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 2.92.